Titlebook: Antigen and Antibody Molecular Engineering in Breast Cancer Diagnosis and Treatment; Roberto L. Ceriani Book 1994 The Editor(s) (if applic

實體

書目名稱Antigen and Antibody Molecular Engineering in Breast Cancer Diagnosis and Treatment影響因子(影響力)




書目名稱Antigen and Antibody Molecular Engineering in Breast Cancer Diagnosis and Treatment影響因子(影響力)學(xué)科排名




書目名稱Antigen and Antibody Molecular Engineering in Breast Cancer Diagnosis and Treatment網(wǎng)絡(luò)公開度




書目名稱Antigen and Antibody Molecular Engineering in Breast Cancer Diagnosis and Treatment網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Antigen and Antibody Molecular Engineering in Breast Cancer Diagnosis and Treatment被引頻次




書目名稱Antigen and Antibody Molecular Engineering in Breast Cancer Diagnosis and Treatment被引頻次學(xué)科排名




書目名稱Antigen and Antibody Molecular Engineering in Breast Cancer Diagnosis and Treatment年度引用




書目名稱Antigen and Antibody Molecular Engineering in Breast Cancer Diagnosis and Treatment年度引用學(xué)科排名




書目名稱Antigen and Antibody Molecular Engineering in Breast Cancer Diagnosis and Treatment讀者反饋




書目名稱Antigen and Antibody Molecular Engineering in Breast Cancer Diagnosis and Treatment讀者反饋學(xué)科排名

meretricious

Peptide Epitopes in Breast Cancer Mucins, is the predominant mucin expressed in breast cancer.. In addition, other genes coding for mucins have been identified which are expressed in a variety of tissues, and are also found in breast tissue and to a lesser extent in breast cancer (particularly MUC2 and MUC3). It was of interest that these

ENDOW

通便

Gnrh670

外星人

充氣女

chiropractor

Humanization of an Anti-Mucin Antibody for Breast and Ovarian Cancer Therapy,oclonal antibody, CTM01 (mCTM0l), which recognizes an epitope on breast epithelial mucin, has potential for the treatment of breast and ovarian cancers. We examine in this paper the comparative properties of mCTM01 against a number of other anti-mucin antibodies. We then describe the humanization an

Gingivitis

Towards an Immunotherapy for p185HER2 Overexpressing Tumors,). . was found to be amplified from 2 to 20-fold in up to ~ 30% of primary human breast cancers.. Furthermore, . amplification was shown to be a strong prognosticator of decreased overall survival and overall time to relapse.. amplification and/or overexpression has subsequently been correlated with

JIBE

Branching N-Linked Oligosaccharides in Breast Cancer,nching, a regulatory step in expression of polylactosamine and extended-chain Lewis antigens. Loss of the branched oligosaccharides in murine tumor cells either due to somatic mutation, or treatment of the cells with the oligosaccharide processing inhibitor swainsonine, blocks tumor cells invasion i